CSPC Baike (Jinan) Biopharmaceutical Co., Ltd., established in 1994, subcompany of CSPC Pharmaceutical Group Limited, is involving in the area of R&D, manufacture and marketing of recombinant DNA pharmaceuticals with registration capital of US$26millions and area of 28000m2. All the buildings and equipment were designed and constructed according to the GMP standard of FDA. Baike Biopharma passed the GMP certificate of State Food and Drug Administration of China in 1999. In the R&D, manufacturing, marketing and sales of new drugs, Baike Biopharma conforms with the international standard of GLP, GCP and GMP.rhG-CSF (Recombinant Human Granulocyte Colony-Stimulating Factor) Injection is our first product on the market, with the trademark of GeneLeukim®. PEG-rhG-CSF (PegFilgrastim) injection is our second product on the market, with the trademark as PegLeukim®. Products under R&D are the followings: Interferon α2a, Interferon α2b, PegInterferon α2a, PegInterferon α2b, Interleukin-2, Interleukin-11, rhGH, rhEPO, HCG and HBsAg etc. We can offer you the bulk of them as requested.